Healthcare provider profile · identity verified

Oleksandr Stupnytskyi, M.D.

Internal Medicine · LAWRENCE, MA · NPI 1598712739

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	660	181
Amlodipine Besylate	Amlodipine Besylate	505	138
Lisinopril	Lisinopril	500	141
Levothyroxine Sodium	Levothyroxine Sodium	444	110
Rosuvastatin Calcium	Rosuvastatin Calcium	383	109
Pravastatin Sodium	Pravastatin Sodium	362	98
Omeprazole	Omeprazole	325	94
Metoprolol Succinate	Metoprolol Succinate	303	85
Olmesartan Medoxomil	Olmesartan Medoxomil	287	76
Eliquis	Apixaban	213	55
Gabapentin	Gabapentin	206	56
Furosemide	Furosemide	203	60
Sertraline Hcl	Sertraline Hcl	193	49
Pantoprazole Sodium	Pantoprazole Sodium	182	57
Simvastatin	Simvastatin	178	48
Allopurinol	Allopurinol	171	48
Tamsulosin Hcl	Tamsulosin Hcl	170	45
Losartan Potassium	Losartan Potassium	163	47
Metoprolol Tartrate	Metoprolol Tartrate	162	46
Metformin Hcl	Metformin Hcl	156	43
Hydrochlorothiazide	Hydrochlorothiazide	148	44
Clonazepam	Clonazepam	133	25
Ezetimibe	Ezetimibe	112	34
Spironolactone	Spironolactone	107	29
Ozempic	Semaglutide	106	27
Trazodone Hcl	Trazodone Hcl	103	32
Januvia	Sitagliptin Phosphate	98	26
Jardiance	Empagliflozin	97	30
Doxycycline Hyclate	Doxycycline Hyclate	95	84
Nebivolol Hcl	Nebivolol Hcl	95	27
Atenolol	Atenolol	90	26
Metformin Hcl Er	Metformin Hcl	90	25
Farxiga	Dapagliflozin Propanediol	88	21
Albuterol Sulfate Hfa	Albuterol Sulfate	80	33
Chlorthalidone	Chlorthalidone	77	25
Clopidogrel	Clopidogrel Bisulfate	77	25
Famotidine	Famotidine	73	22
Duloxetine Hcl	Duloxetine Hcl	68	23
Lorazepam	Lorazepam	66	17
Donepezil Hcl	Donepezil Hcl	55	15
Trulicity	Dulaglutide	55	13
Alendronate Sodium	Alendronate Sodium	54	16
Tramadol Hcl	Tramadol Hcl	53	13
Potassium Chloride	Potassium Chloride	51	16
Carvedilol	Carvedilol	50	12
Irbesartan	Irbesartan	49	14
Mirtazapine	Mirtazapine	49	14
Pioglitazone Hcl	Pioglitazone Hcl	49	13
Glimepiride	Glimepiride	48	15
Alprazolam	Alprazolam	47	11
Escitalopram Oxalate	Escitalopram Oxalate	46	18
Ibuprofen	Ibuprofen	46	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	14
Fluticasone Propionate	Fluticasone Propionate	44	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	14
Xarelto	Rivaroxaban	42	suppressed
Bupropion Hcl Sr	Bupropion Hcl	40	11
Synthroid	Levothyroxine Sodium	40	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	13
Prednisone	Prednisone	39	27
Zolpidem Tartrate	Zolpidem Tartrate	39	11
Colchicine	Colchicine	38	12
Entresto	Sacubitril/Valsartan	37	suppressed
Lovastatin	Lovastatin	37	suppressed
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	36	11
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Folic Acid	Folic Acid	36	suppressed
Terazosin Hcl	Terazosin Hcl	36	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	34	34
Triamcinolone Acetonide	Triamcinolone Acetonide	34	16
Warfarin Sodium	Warfarin Sodium	34	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	33	suppressed
Azithromycin	Azithromycin	32	29
Nystatin	Nystatin	31	17
Digoxin	Digoxin	30	suppressed
Novolog Flexpen	Insulin Aspart	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Fenofibrate	Fenofibrate,micronized	27	suppressed
Livalo	Pitavastatin Calcium	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Propranolol Hcl Er	Propranolol Hcl	27	suppressed
Pregabalin	Pregabalin	26	suppressed
Amoxicillin	Amoxicillin	25	18
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	20
Ondansetron Odt	Ondansetron	25	suppressed
Valsartan	Valsartan	25	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	12
Finasteride	Finasteride	24	suppressed
Gemfibrozil	Gemfibrozil	24	suppressed
Labetalol Hcl	Labetalol Hcl	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Prolia	Denosumab	23	15
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	23	suppressed
Linzess	Linaclotide	22	suppressed
Repatha Sureclick	Evolocumab	22	suppressed
Repatha Syringe	Evolocumab	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Methylprednisolone	Methylprednisolone	21	19
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	17
Buspirone Hcl	Buspirone Hcl	19	suppressed
Tradjenta	Linagliptin	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	15
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Nitroglycerin	Nitroglycerin	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Bystolic	Nebivolol Hcl	15	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	15	13
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Ofloxacin	Ofloxacin	14	11
Torsemide	Torsemide	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Dilt-Xr	Diltiazem Hcl	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Klor-Con M10	Potassium Chloride	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	13	suppressed
Praluent Pen	Alirocumab	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Cephalexin	Cephalexin	12	12
Epinephrine	Epinephrine	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Baclofen	Baclofen	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Crestor	Rosuvastatin Calcium	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error